How have AIKI shares performed in 2024?

AIkido Pharma's stock was trading at $2.59 on January 1st, 2024. Since then, AIKI stock has increased by 4.2% and is now trading at $2.70. View the best growth stocks for 2024 here .

When did AIkido Pharma's stock split?

AIkido Pharma's stock reverse split on Tuesday, June 7th 2022. The 1-17 reverse split was announced on Tuesday, June 7th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 7th 2022. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

What other stocks do shareholders of AIkido Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AIkido Pharma investors own include Biocept (BIOC) , AIM ImmunoTech (AIM) , Nuwellis (CHFS) , Foresight Autonomous (FRSX) , iBio (IBIO) , Exela Technologies (XELA) , Bionano Genomics (BNGO) , Check-Cap (CHEK) , Digital Ally (DGLY) and Purple Biotech (KTOV) .

How do I buy shares of AIkido Pharma?

Shares of AIKI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does AIkido Pharma have any subsidiaries?

The following companies are subsidiares of AIkido Pharma: Hoth Therapeutics. Read More

NASDAQ:AIKI

AIkido Pharma (AIKI) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free AIKI Stock Alerts

$2.70

-0.10 (-3.57%)

(As of 04/19/2024 ET)

Compare

Today's Range: $2.70
▼
$2.83
50-Day Range: $1.95
▼
$2.93
52-Week Range: $3.31
▼
$11.48

Volume: 12,066 shs
Average Volume: 79,326 shs
Market Capitalization: $14.81 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Insider Trades SEC Filings Social Media

Get AIkido Pharma alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About AIkido Pharma Stock (NASDAQ:AIKI)

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

AIKI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AIKI Stock News Headlines

April 16, 2024 | americanbankingnews.com

AIkido Pharma (NASDAQ:AIKI) Shares Pass Above 200 Day Moving Average of $2.23

March 17, 2024 | seekingalpha.com

SNOA Sonoma Pharmaceuticals, Inc.

April 20, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

January 23, 2024 | wsj.com

Royalty Pharma PLC

October 6, 2023 | msn.com

Kengan Ashura: 10 Strongest Fighters, Ranked

September 6, 2023 | markets.businessinsider.com

Dominari Holdings Inc. Releases Shareholder Update

April 10, 2023 | markets.businessinsider.com

Kyle Wool Appears on Fox Business

April 3, 2023 | markets.businessinsider.com

Dominari Holdings Appoints George Way As CFO

April 20, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

March 27, 2023 | markets.businessinsider.com

Dominari Financial Inc. Acquires Leading Broker Dealer and Registered Investment Advisor Business

March 21, 2023 | benzinga.com

Dominari Financial Granted Approval to Acquire Broker Dealer

March 14, 2023 | finance.yahoo.com

Dominari Holdings Provides Business Update

December 28, 2022 | finance.yahoo.com

Dominari Holdings Provides Update on Share Repurchase Program

December 22, 2022 | finanznachrichten.de

AIkido Pharma Inc.: AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes

December 22, 2022 | finance.yahoo.com

AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)

November 28, 2022 | finance.yahoo.com

AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes

October 6, 2022 | finance.yahoo.com

AIkido Share Repurchase Continues

October 5, 2022 | finance.yahoo.com

AIkido Purchases More Shares

October 4, 2022 | finance.yahoo.com

Share Repurchase Program Continues

October 3, 2022 | finance.yahoo.com

AIkido Pharma Continues Share Repurchase Program

September 30, 2022 | finance.yahoo.com

AIkido Pharma Provides Update on Share Repurchase Program

September 9, 2022 | prnewswire.com

Dominari Financial, Inc. Executes Definitive Agreement to Buy Broker-Dealer

August 10, 2022 | ca.investing.com

Pre-Open Movers: Nielsen Climbs 20%, AppLivin Makes Offer for Unity

August 10, 2022 | marketwatch.com

AIkido Pharma Gets $8/Share Buyout Offer From Shalom Auerbach >AIKI

August 10, 2022 | nasdaq.com

AIkido Pharma Receives Offer From Shalom Auerbach - Quick Facts

August 10, 2022 | finance.yahoo.com

AIkido Pharma Confirms Receipt of Unsolicited Offer

August 9, 2022 | finance.yahoo.com

Investor Makes Proposal to Acquire AIkido Pharma for $8.00 Per Share in Cash

See More Headlines

Receive AIKI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AIkido Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Commercial physical research
Sub-Industry: N/A
Current Symbol: NASDAQ:AIKI
CUSIP: N/A
CIK: 12239
Web: www.spherix.com
Phone: (112) 745-1374
Fax: 703-992-9348
Employees: 4
Year Founded: 1967

Profitability

EPS (Most Recent Fiscal Year): ($3.88)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-7,170,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -18.21%
Return on Assets: -16.94%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 29.54
Quick Ratio: 29.54

Sales & Book Value

Annual Sales: $10,000.00
Price / Sales: 1,480.95
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $19.27 per share
Price / Book: 0.14

Miscellaneous

Outstanding Shares: 5,485,000
Free Float: 5,013,000
Market Cap: $14.81 million
Optionable: Not Optionable
Beta: 0.93

Social Links

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Anthony C. Hayes Esq. (Age 54)
CEO, Principal Financial Officer, Principal Accounting Officer & Director
Comp: $960k
Mr. Darrell Dotson
VP of Drug Devel. & Gen. Counsel
Mr. Carlos Aldavero
Pres of Dominari Financial

Key Competitors

View All Competitors

AIKI Stock Analysis - Frequently Asked Questions

How have AIKI shares performed in 2024?: AIkido Pharma's stock was trading at $2.59 on January 1st, 2024. Since then, AIKI stock has increased by 4.2% and is now trading at $2.70.
View the best growth stocks for 2024 here.
When did AIkido Pharma's stock split?: AIkido Pharma's stock reverse split on Tuesday, June 7th 2022. The 1-17 reverse split was announced on Tuesday, June 7th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 7th 2022. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.
What other stocks do shareholders of AIkido Pharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other AIkido Pharma investors own include Biocept (BIOC), AIM ImmunoTech (AIM), Nuwellis (CHFS), Foresight Autonomous (FRSX), iBio (IBIO), Exela Technologies (XELA), Bionano Genomics (BNGO), Check-Cap (CHEK), Digital Ally (DGLY) and Purple Biotech (KTOV).

How do I buy shares of AIkido Pharma?: Shares of AIKI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does AIkido Pharma have any subsidiaries?: The following companies are subsidiares of AIkido Pharma: Hoth Therapeutics.
Read More

This page (NASDAQ:AIKI) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial